Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know
Myriad Genetics stock fell after hours after weak Q2 results, lower guidance and an operating loss.
Myriad Genetics made less money than people hoped in the last three months, and the company said future results might be weaker too. When a company disappoints like this, it's a signal to watch whether they can turn things around or if problems are getting bigger.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.